APA (7th ed.) Citation

Lord, S. R., & Harris, A. L. (2023). Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? British journal of cancer, 128(6), 958-966. https://doi.org/10.1038/s41416-023-02204-2

Chicago Style (17th ed.) Citation

Lord, Simon R., and Adrian L. Harris. "Is It Still Worth Pursuing the Repurposing of Metformin as a Cancer Therapeutic?" British Journal of Cancer 128, no. 6 (2023): 958-966. https://doi.org/10.1038/s41416-023-02204-2.

MLA (9th ed.) Citation

Lord, Simon R., and Adrian L. Harris. "Is It Still Worth Pursuing the Repurposing of Metformin as a Cancer Therapeutic?" British Journal of Cancer, vol. 128, no. 6, 2023, pp. 958-966, https://doi.org/10.1038/s41416-023-02204-2.